𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Continuous 5-fluorouracil infusion in refractory carcinoma of the breast

✍ Scribed by Richard Hansen; Edward Quebbeman; Peter Beatty; Paul Ritch; Tom Anderson; David Jenkins; Jacob Frick; Robert Ausman

Publisher
Springer US
Year
1987
Tongue
English
Weight
444 KB
Volume
10
Category
Article
ISSN
0167-6806

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

5-fluorouracil rechallenge by protracted
5-fluorouracil rechallenge by protracted infusion in refractory breast cancer
✍ Khaled Jabboury; Frankie Ann Holmes; Gabriel Hortobagyi πŸ“‚ Article πŸ“… 1989 πŸ› John Wiley and Sons 🌐 English βš– 489 KB πŸ‘ 1 views

The authors assessed the value of protracted low-dose 5-fluorouracil (5-FU) infusion (250 mg/m\*/day) in refractory breast cancer. Thirty-six patients with prior 5-FU exposure who were not eligible for other investigational therapeutic measures mainly due to extensive prior chemotherapy (median, fou

9-aminocamptothecin by 72-hour continuou
9-aminocamptothecin by 72-hour continuous intravenous infusion is Inactive in the treatment of patients with 5-fluorouracil-refractory colorectal carcinoma
✍ Leonard B. Saltz; Nancy E. Kemeny; William Tong; John Harrison; Regina Berkery; πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 78 KB πŸ‘ 2 views

thecin, have shown outstanding preclinical activity against colorectal carcinoma. Irinotecan (CPT-11), another camptothecin derivative, has demonstrated clinical

Bimonthly high dose leucovorin and 5-flu
Bimonthly high dose leucovorin and 5-fluorouracil 48-hour continuous infusion in patients with advanced colorectal carcinoma
✍ Karine Beerblock; Yves Rinaldi; Thierry AndrΓ©; Christophe Louvet; Eric Raymond; πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 86 KB πŸ‘ 2 views

with low dose LV. Based on these reports, a first-line Phase II study was performed in 101 patients with advanced colorectal carcinoma who were given a bimonthly